Project PERCH brings together 18 European countries and 34 partner organizations with the objective of contributing to the implementation of Europe’s Beating Cancer Plan. PERCH aligns with the World Health Organization’s (WHO) “90-70-90” strategy, aiming to achieve at least 90% HPV vaccination coverage among girls, and potentially boys, by the age of 15 years.
Project objectives are:
On 17 November 2023 PERCH met students, teachers and parents from some schools in Basilicata participating in the Project to address aspects relating to HPV and its prevention.
The meetings will also continue in other Italian regions involved in the PERCH project.
On 13 November 2023 PERCH met students, teachers and parents from some schools in Puglia participating in the Project to address aspects relating to HPV and its prevention.
The meetings will also continue in other Italian regions involved in the PERCH project.
On 10 November 2023 PERCH met students, teachers and parents from some schools in Piemonte participating in the Project to address aspects relating to HPV and its prevention.
The meetings will also continue in other Italian regions involved in the PERCH project.
On 31 October 2023 PERCH met students, teachers and parents from some schools in Calabria participating in the Project to address aspects relating to HPV and its prevention.
The meetings will also continue in other Italian regions involved in the PERCH project.
‘PERCH’: EUROPEAN COUNTRIES JOIN FORCES TO BOOST HPV VACCINATION
The published interview shedding light on PERCH impactful mission in Vaccines Today.
Subscribe to PERCH newsletter and get the latest updates from European Partnership to Contrast HPV
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not re!ect those of the European Union or European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not re!ect those of the European Union or European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.
